Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Antibiotics for treating gonorrhoea in pregnancy.

Comunián-Carrasco G, Peña-Martí GE, Martí-Carvajal AJ.

Cochrane Database Syst Rev. 2018 Feb 21;2:CD011167. doi: 10.1002/14651858.CD011167.pub2. Review.

PMID:
29465747
2.

Effectiveness of syndromic management for male patients with urethral discharge symptoms in Amazonas, Brazil.

Menezes Filho JR, Sardinha JCG, Galbán E, Saraceni V, Talhari C.

An Bras Dermatol. 2017 Nov-Dec;92(6):779-784. doi: 10.1590/abd1806-4841.20175453.

3.

Neisseria gonorrhoeae co-infection exacerbates vaginal HIV shedding without affecting systemic viral loads in human CD34+ engrafted mice.

Xu SX, Leontyev D, Kaul R, Gray-Owen SD.

PLoS One. 2018 Jan 23;13(1):e0191672. doi: 10.1371/journal.pone.0191672. eCollection 2018.

4.

Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.

Buder S, Dudareva S, Jansen K, Loenenbach A, Nikisins S, Sailer A, Guhl E, Kohl PK, Bremer V; GORENET study group.

BMC Infect Dis. 2018 Jan 17;18(1):44. doi: 10.1186/s12879-018-2944-9.

5.

Antibiotic susceptibility pattern of Neisseria gonorrhoeae strains isolated from five cities in India during 2013-2016.

Kulkarni SV, Bala M, Muqeeth SA, Sasikala G, Nirmalkar AP, Thorat R, Kambli H, Sawant J, Risbud A, Gangakhedkar RR, Godbole SV.

J Med Microbiol. 2018 Jan;67(1):22-28. doi: 10.1099/jmm.0.000662. Epub 2017 Dec 12.

PMID:
29231153
6.

Advancing prevention of sexually transmitted infections through point-of-care testing: target product profiles and landscape analysis.

Toskin I, Murtagh M, Peeling RW, Blondeel K, Cordero J, Kiarie J.

Sex Transm Infect. 2017 Dec;93(S4):S69-S80. doi: 10.1136/sextrans-2016-053071.

7.

Performance and operational characteristics of point-of-care tests for the diagnosis of urogenital gonococcal infections.

Guy RJ, Causer LM, Klausner JD, Unemo M, Toskin I, Azzini AM, Peeling RW.

Sex Transm Infect. 2017 Dec;93(S4):S16-S21. doi: 10.1136/sextrans-2017-053192. Review.

8.

Comparison of the Cepheid GeneXpert CT/NG assay to the Hologic Aptima Combo2 assay for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in self-collected rectal swabs.

Dize L, Silver B, Gaydos C.

Diagn Microbiol Infect Dis. 2018 Feb;90(2):83-84. doi: 10.1016/j.diagmicrobio.2017.10.013. Epub 2017 Oct 26.

PMID:
29174733
9.

Estimating the fitness cost and benefit of cefixime resistance in Neisseria gonorrhoeae to inform prescription policy: A modelling study.

Whittles LK, White PJ, Didelot X.

PLoS Med. 2017 Oct 31;14(10):e1002416. doi: 10.1371/journal.pmed.1002416. eCollection 2017 Oct.

10.

Impact of Rapid Susceptibility Testing and Antibiotic Selection Strategy on the Emergence and Spread of Antibiotic Resistance in Gonorrhea.

Tuite AR, Gift TL, Chesson HW, Hsu K, Salomon JA, Grad YH.

J Infect Dis. 2017 Nov 27;216(9):1141-1149. doi: 10.1093/infdis/jix450.

11.

A chronological study of the bacterial pathogen changes in acute neonatal bacterial conjunctivitis in southern China.

Tang S, Li M, Chen H, Ping G, Zhang C, Wang S.

BMC Ophthalmol. 2017 Sep 26;17(1):174. doi: 10.1186/s12886-017-0570-8.

12.

Cervical precancerous changes and selected cervical microbial infections, Kiambu County, Kenya, 2014: a cross sectional study.

Kanyina EW, Kamau L, Muturi M.

BMC Infect Dis. 2017 Sep 25;17(1):647. doi: 10.1186/s12879-017-2747-4.

13.

Condom use and incident sexually transmitted infection after initiation of long-acting reversible contraception.

McNicholas CP, Klugman JB, Zhao Q, Peipert JF.

Am J Obstet Gynecol. 2017 Dec;217(6):672.e1-672.e6. doi: 10.1016/j.ajog.2017.09.009. Epub 2017 Sep 14.

PMID:
28919400
14.

Rural counties chlamydia and gonorrhea rates in Pennsylvania among adolescents and young adults.

Pinto CN, Dorn LD, Chinchilli VM, Du P, Chi G.

Ann Epidemiol. 2017 Sep;27(9):606-610.e2. doi: 10.1016/j.annepidem.2017.08.018. Epub 2017 Aug 24.

PMID:
28893492
15.

Use of Patient-Delivered Partner Therapy in US College Settings: Associations With Legality, Perceived Legality and Other Sexual and Reproductive Health Services.

Hogben M, Caccamo A, Beltran O, Cramer R, Habel MA.

Sex Transm Dis. 2017 Nov;44(11):648-652. doi: 10.1097/OLQ.0000000000000671.

PMID:
28876309
16.

The impact of HIV infection and socioeconomic factors on the incidence of gonorrhea: A county-level, US-wide analysis.

Andreatos N, Grigoras C, Shehadeh F, Pliakos EE, Stoukides G, Port J, Flokas ME, Mylonakis E.

PLoS One. 2017 Sep 1;12(9):e0183938. doi: 10.1371/journal.pone.0183938. eCollection 2017.

17.

The antibiotic management of gonorrhoea in Ontario, Canada following multiple changes in guidelines: an interrupted time-series analysis.

Dickson C, Taljaard M, Friedman DS, Metz G, Wong T, Grimshaw JM.

Sex Transm Infect. 2017 Dec;93(8):561-565. doi: 10.1136/sextrans-2017-053224. Epub 2017 Aug 26.

PMID:
28844044
18.

New Hope for a Gonorrhea Vaccine.

Abbasi J.

JAMA. 2017 Sep 12;318(10):894-895. doi: 10.1001/jama.2017.11037. No abstract available.

PMID:
28832870
19.

Persistence after treatment of pharyngeal gonococcal infections in patients of the STI clinic, Amsterdam, the Netherlands, 2012-2015: a retrospective cohort study.

Hananta IPY, De Vries HJC, van Dam AP, van Rooijen MS, Soebono H, Schim van der Loeff MF.

Sex Transm Infect. 2017 Nov;93(7):467-471. doi: 10.1136/sextrans-2017-053147. Epub 2017 Aug 19.

20.

Using Reported Rates of Sexually Transmitted Diseases to Illustrate Potential Methodological Issues in the Measurement of Racial and Ethnic Disparities.

Chesson HW, Patel CG, Gift TL, Bernstein KT, Aral SO.

Sex Transm Dis. 2017 Sep;44(9):513-518. doi: 10.1097/OLQ.0000000000000646.

PMID:
28809767

Supplemental Content

Loading ...
Support Center